EISAI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,793 JPY | +1.55% |
|
+3.79% | -3.67% |
| May. 06 | People with two copies of a risk gene have genetic form of Alzheimer's, scientists say | RE |
| Apr. 24 | Biogen beats quarterly profit estimates, Alzheimer's drug sales jump | RE |
Presenter SpeechUnknown Executive (Executives)It is now time. We would like to begin financial...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;
- other (12.3%): food additives, chemical products, etc.
Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6,793
JPY
Average target price
8,162
JPY
Spread / Average Target
+20.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.67% | 12.5B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Transcript : Eisai Co., Ltd., Q2 2021 Earnings Call, Nov 05, 2020